New MRI-Guided Therapy Navigates Magnetic Seed Through Brain to Heat and Destroy Tumors
|
By HospiMedica International staff writers Posted on 03 Feb 2022 |

Scientists have developed a novel cancer therapy that uses an MRI scanner to guide a magnetic seed through the brain to heat and destroy tumors.
The therapy, demonstrated by scientists at University College London (London, UK), in mice, is called “minimally invasive image-guided ablation” or MINIMA and comprises a ferromagnetic thermoseed navigated to a tumor using magnetic propulsion gradients generated by an MRI scanner, before being remotely heated to kill nearby cancer cells. The researchers say their findings establish ‘proof-of-concept’ for precise and effective treatment of hard-to-reach glioblastoma, along with other cancers such as prostate, that could benefit from less invasive therapies.
In the study, the UCL team demonstrated the three key components of MINIMA to a high level of accuracy: precise seed imaging; navigation through brain tissue using a tailored MRI system, tracked to within 0.3 mm accuracy; and eradicating the tumor by heating it in a mouse model. Ferromagnetic thermoseeds are spherical in shape, 2 mm in size and are made of a metal alloy; they are implanted superficially into tissue before being navigated to the cancer. MRI scanners are readily available in hospitals around the world and are pivotal in the diagnosis of diseases such as cancer. The work at UCL shows that MINIMA has the potential to elevate an MRI scanner from a diagnostic device to a therapeutic platform.
“MINIMA is a new MRI-guided therapy that has the potential to avoid traditional side effects by precisely treating the tumor without harming healthy tissues,” said senior author, Professor Mark Lythgoe (UCL Centre for Advanced Biomedical Imaging). “Because the heating seed is magnetic, the magnetic fields in the MRI scanner can be used to remotely steer the seed through tissue to the tumor. Once at the tumor, the seed can then be heated, destroying the cancer cells, while causing limited damage to surrounding healthy tissues.”
“Using an MRI scanner to deliver a therapy in this way allows the therapeutic seed and the tumor to be imaged throughout the procedure, ensuring the treatment is delivered with precision and without having to perform open surgery,” added lead author, Rebecca Baker, (UCL Centre for Advanced Biomedical Imaging). “This could be beneficial to patients by reducing recovery times and minimizing the chance of side effects.”
Related Links:
University College London
Latest Surgical Techniques News
- BD Launches Elyra Laser Platform for Kidney Stone and Soft Tissue Procedures
- Stretchable Bioelectronic Implant Lowers Blood Pressure in Preclinical Study
- FDA-Cleared Nerve Stimulator Advances Intraoperative Peripheral Nerve Assessment
- Intravascular Lithotripsy Catheter Advances Treatment of Calcified Coronary Disease
- Handheld AI Endomicroscope Enables Real-Time Precancer Detection at Point of Care
- Photoacoustic Imaging System Maps Hidden Nerves and Vessels in Robotic Laparoscopy
- Smart Soft Sensors Provide Real-Time Force Feedback in Minimally Invasive Surgery
- Advanced Endoscopy Platform Targets Challenging Upper GI Procedures
- Ultrasonic Fine-Needle Biopsy Tool Improves Salivary Gland Tumor Diagnosis
- Robotic Microsurgery System Gains CE Mark for Clinical Use in Europe
- New Endoscopic Device Offers Minimally Invasive Approach to Obesity Management
- Handheld Probe Enables Real-Time Tumor Mapping in Breast-Conserving Surgery
- Robotic Surgical System Enables Gastric Bypass in Space-Constrained Operating Rooms
- Optical Wireless Link Enables Cable-Free 4K Endoscopic Imaging
- Patient-Specific 3D-Printed Guide Improves Precision in Breast-Conserving Surgery
- Glasses-Free 3D Imaging Software Receives FDA Clearance for Surgical Planning
Channels
Artificial Intelligence
view channel
Automated Phone Speech Test Identifies Alzheimer’s Pathology for Prescreening
Alzheimer’s disease assessment and trial recruitment often rely on costly, invasive biomarker testing and clinic-based cognitive evaluations, limiting scalability as populations age. Providers and trial... Read more
FDA-Cleared AI System Detects Sepsis Earlier and Reduces Mortality
Sepsis remains one of the deadliest complications for hospitalized patients, in part because its early signs overlap with other conditions. Each hour of delayed recognition measurably decreases survival,... Read moreCritical Care
view channel
Implantable Wireless Light Device Advance Bladder Cancer Treatment
Bladder cancer, a malignancy of the urinary bladder, often requires local therapies that spare surrounding tissue. Photodynamic therapy uses light-activated drugs but is limited by poor light penetration... Read more
AI-Enabled Wearable Patches Reveal Undetected Hormone Disruption in Infertility
Unexplained infertility, diagnosed when routine evaluations identify no clear cause, affects 15–30% of couples and often leaves patients with limited options. Standard testing typically captures hormone... Read morePatient Care
view channel
AI Avatar Doctor Improves Patient Understanding Before Radiotherapy
Radiation oncology consultations require patients to grasp complex concepts quickly, yet anxiety and information overload often undermine understanding and informed consent. Poor comprehension can also... Read more
Wearable Sleep Data Predict Adherence to Pulmonary Rehabilitation
Chronic obstructive pulmonary disease (COPD) is a long-term lung disorder that makes breathing difficult and often disturbs sleep, reducing energy for daily activities. Limited engagement in pulmonary... Read moreHealth IT
view channel
EHR-Integrated Screening Workflow Detects Cognitive Impairment at Admission
Cognitive impairment involves difficulties with thinking, learning, memory, and decision-making, and is more common in older adults. In U.S. hospitals, more than 40% of admitted older adults have dementia,... Read more
AI System Detects and Quantifies Chronic Subdural Hematoma
Viz.ai (San Francisco, CA, USA) announced a strategic commercialization collaboration with Johnson & Johnson (New Brunswick, NJ, USA) to expand access in the United States to the Viz Subdural solution... Read more
Continuous Monitoring Platform Detects Infection Risk Across Care Transitions
Patients leaving skilled nursing facilities often lose continuous physiologic monitoring, increasing the risk of undetected infection and delayed intervention. Nursing home residents are seven times more... Read more
Automated System Classifies and Tracks Cardiogenic Shock Across Hospital Settings
Cardiogenic shock remains a difficult, time-sensitive emergency, with delayed identification driving poor outcomes and persistently high mortality. Many cases go undocumented even at advanced stages, hindering... Read morePoint of Care
view channel
Point-of-Care Viscoelastic Testing System Supports Obstetric Bleeding Management
HemoSonics (Durham, NC, USA) announced on May 5, 2026 that the company's Quantra Hemostasis System for Obstetric Procedures won Silver in the 2026 Edison Awards in the Women’s Health and Reproductive Innovations... Read moreBusiness
view channel
Olympus Partnership Aims to Expand Access to Robot-Assisted Endoscopic Therapy
Olympus has signed an exclusive global distribution agreement with EndoRobotics Co., Ltd., under which robot-assisted technologies developed by EndoRobotics will be distributed worldwide as part of the... Read more







